• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[具有多聚谷氨酰胺重复序列的蛋白质的聚集与毒性]

[Aggregation and toxicity of the proteins with polyQ repeats].

作者信息

Leźnicki Paweł

机构信息

Department of Molecular and Cellular Biology, Intercollegiate Faculty of Biotechnology, University of Gdańsk, Gdańsk, Poland.

出版信息

Postepy Biochem. 2005;51(2):215-22.

PMID:16209359
Abstract

Expansion of CAG triplet repeats is a cause of at least nine late-onset neurodegenerative disorders. The mutation manifests itself as a long stretch of glutamine repeats. The number of approximately 38 repeats is usually a threshold at which the disease develops and the longer the polyglutamine tract, the earlier the onset of disease. A common feature of these disorders is the presence of protein aggregates which are believed to be formed either by the formation of hydrogen bonds between amide residues or through the action of the enzyme transglutaminase. Mutated proteins may cause neurodegeneration by sequestering vital cellular proteins, inhibiting proteasomal system or by inducing apoptosis. It has been proved that molecular chaperones may block the negative effects of expression of mutated genes and for this reason they are a promising object for various therapeutic research.

摘要

CAG三联体重复序列的扩增是至少九种迟发性神经退行性疾病的病因。该突变表现为一段长的谷氨酰胺重复序列。大约38次重复通常是疾病发生的阈值,聚谷氨酰胺序列越长,疾病发作越早。这些疾病的一个共同特征是存在蛋白质聚集体,据信这些聚集体是由酰胺残基之间形成氢键或通过转谷氨酰胺酶的作用形成的。突变蛋白可能通过隔离重要的细胞蛋白、抑制蛋白酶体系统或诱导细胞凋亡来导致神经退行性变。已经证明分子伴侣可能会阻断突变基因表达的负面影响,因此它们是各种治疗研究的一个有前景的对象。

相似文献

1
[Aggregation and toxicity of the proteins with polyQ repeats].[具有多聚谷氨酰胺重复序列的蛋白质的聚集与毒性]
Postepy Biochem. 2005;51(2):215-22.
2
Polyglutamine-mediated aggregation and cell death.多聚谷氨酰胺介导的聚集与细胞死亡。
Biochem Biophys Res Commun. 2000 Jun 16;272(3):816-21. doi: 10.1006/bbrc.2000.2843.
3
Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.分析聚谷氨酰胺扩展蛋白的聚集及其被分子伴侣的调节。
Methods. 2011 Mar;53(3):267-74. doi: 10.1016/j.ymeth.2010.12.035. Epub 2010 Dec 30.
4
[Molecular biology of polyglutamine diseases].[多聚谷氨酰胺疾病的分子生物学]
Postepy Hig Med Dosw. 2002;56(6):779-88.
5
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.分子伴侣作为多聚谷氨酰胺蛋白聚集和毒性的调节剂。
Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4(Suppl 4):16412-8. doi: 10.1073/pnas.182426899. Epub 2002 Aug 20.
6
Polyglutamine diseases and molecular chaperones.多聚谷氨酰胺疾病与分子伴侣
IUBMB Life. 2003 Jun;55(6):337-45. doi: 10.1080/1521654032000114339.
7
The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates.聚谷氨酰胺序列的长度、其表达水平、降解速率以及转谷氨酰胺酶活性会影响细胞内聚集体的形成。
Biochem Biophys Res Commun. 1999 Jun 24;260(1):150-8. doi: 10.1006/bbrc.1999.0851.
8
The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.多聚谷氨酰胺疾病的致病机制及当前的治疗策略。
J Neurochem. 2009 Sep;110(6):1737-65. doi: 10.1111/j.1471-4159.2009.06302.x. Epub 2009 Jul 23.
9
Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies.具有8至45个残基的聚谷氨酰胺均聚物形成板状β-微晶聚集体。
Proteins. 2005 Nov 1;61(2):398-411. doi: 10.1002/prot.20602.
10
Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.模拟蛋白酶体释放多聚谷氨酰胺肽会引发聚集和毒性。
J Cell Sci. 2009 Sep 15;122(Pt 18):3262-71. doi: 10.1242/jcs.045567. Epub 2009 Aug 18.

引用本文的文献

1
A comprehensive review of spinocerebellar ataxia type 2 in Cuba.古巴脊髓小脑共济失调 2 型的全面综述。
Cerebellum. 2011 Jun;10(2):184-98. doi: 10.1007/s12311-011-0265-2.